EMA — authorised 23 November 2011
- Application: EMEA/H/C/002200
- Marketing authorisation holder: Dyax s.a.
- Local brand name: Kalbitor
- Status: withdrawn
🇪🇺 Kalbitor in European Union
EMA authorised Kalbitor on 23 November 2011
Marketing authorisation
Kalbitor in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in European Union
Frequently asked questions
Is Kalbitor approved in European Union?
Yes. EMA authorised it on 23 November 2011.
Who is the marketing authorisation holder for Kalbitor in European Union?
Dyax s.a. holds the EU marketing authorisation.